Canada· CA-DIN-02473968
ODAN-SODIUM POLYSTYRENE SULFONATE
A polystyrene sulfonate product containing sodium polystyrene sulfonate, registered in Canada by ODAN LABORATORIES LTD. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Polystyrene sulfonate is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AE01 (polystyrene sulfonate), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Polystyrene sulfonate · ATC V03AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of polystyrene sulfonate costs, country by country.
Normalised to the WHO defined daily dose (45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Polystyrene sulfonate · price per daily dose (45 g)
USD · FX 28 Sept 2026
- CZ Czechia$0.0074
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- SODIUM POLYSTYRENE SULFONATE
- Manufacturer
- ODAN LABORATORIES LTD
- Country
- Canada (CA)
- ATC code
- V03AE01
- ATC class
- Polystyrene sulfonate
- Defined daily dose
- 45 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Polystyrene sulfonate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKionexANI Pharmaceuticals, Inc.
- GermanyAnti-Kalium NaMedice Arzneimittel Pütter Gmbh & Co. Kg
- Japanポリスチレンスルホン酸ナトリウム扶桑薬品工業
- FrancePOLYSTYRENE SULFONATE DE SODIUM SUBSTIPHARM 454 g, poudre pour suspension orale et rectaleSUBSTIPHARM
- United KingdomResonium A powderSanofi
- BelgiumKayexalate Sodium 14.99 gSanofi Belgium
- FinlandResoniumSanofi Oy
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Resonium A
- Belgium · Kayexalate Sodium
- Cyprus · Resinsodio
- Germany · Anti-Kalium Na, Elutit®-Natrium-As
- Spain · Resinsodio
- Finland · Resonium
- France · Kayexalate, Lykasty
- United Kingdom (Northern Ireland) · Resonium A
- Hungary · Resonium
- Italy · Kayexalate
- Luxembourg · Kayexalate Sodium
- Netherlands · Natriumpolystyreensulfonaat Focus, Resonium A
- Poland · Resonium A
- Portugal · Resonium
- Sweden · Resonium
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/80c08b8d-9884-459d-a320-76c4aeb6ca02 GET /v1/drugs/80c08b8d-9884-459d-a320-76c4aeb6ca02?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02473968",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"RECTAL",
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V03AE01",
"schedule": [
"Prescription"
],
"drug_code": "96397",
"strengths": [
"250 MG"
],
"ahfs_class": null,
"substances": [
"SODIUM POLYSTYRENE SULFONATE"
],
"product_categorization": null
}See everything about polystyrene sulfonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.